MTHFR and Parkinson disease: Note that the significantly lower levels of THF and MTHF and no longer decreased betaine in DOPA+ PD subjects with dementia are clear evidence of the inhibitory effect of elevated SAM on methylenetetrahydrofolate reductase [38] and BHMT [39] (previously low betaine in DOPA− subjects increased back to normal in DOPA+ subjects).